[go: up one dir, main page]

BR8707352A - Fosfopeptidios - Google Patents

Fosfopeptidios

Info

Publication number
BR8707352A
BR8707352A BR8707352A BR8707352A BR8707352A BR 8707352 A BR8707352 A BR 8707352A BR 8707352 A BR8707352 A BR 8707352A BR 8707352 A BR8707352 A BR 8707352A BR 8707352 A BR8707352 A BR 8707352A
Authority
BR
Brazil
Prior art keywords
phosphopeptides
compositions
phosphohistidine
phosphothreonine
phosphopeptide
Prior art date
Application number
BR8707352A
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Univ Melbourne
Victorian Dairy Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR8707352(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne
Publication of BR8707352A publication Critical patent/BR8707352A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Cereal-Derived Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
BR8707352A 1986-06-12 1987-06-12 Fosfopeptidios BR8707352A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH638586 1986-06-12
PCT/AU1987/000172 WO1987007615A1 (en) 1986-06-12 1987-06-12 Phosphopeptides

Publications (1)

Publication Number Publication Date
BR8707352A true BR8707352A (pt) 1988-09-13

Family

ID=3771654

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8707352A BR8707352A (pt) 1986-06-12 1987-06-12 Fosfopeptidios

Country Status (12)

Country Link
EP (1) EP0268663B1 (pt)
JP (1) JPH0776235B2 (pt)
AT (1) ATE132161T1 (pt)
BR (1) BR8707352A (pt)
CA (1) CA1315480C (pt)
DE (1) DE3751652T2 (pt)
DK (1) DK173565B1 (pt)
FI (1) FI92709C (pt)
HU (1) HUT47309A (pt)
NO (1) NO178665C (pt)
NZ (1) NZ220673A (pt)
WO (1) WO1987007615A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606674A (en) * 1984-04-23 1986-08-19 Capron Mark E Structural wheel element
GB8811830D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
GB8811829D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
ATE153344T1 (de) * 1989-04-07 1997-06-15 Univ South Alabama Hemmung von mineralabsetzung mit hilfe von phosphorylierten und ähnlichen polyanionischen peptiden
US5290685A (en) * 1990-02-22 1994-03-01 Meiji Milk Products Company Limited Method for separation and concentration of phosphopeptides
DE4007431A1 (de) * 1990-03-09 1991-09-12 Henkel Kgaa Den zahnschmelz schuetzende mund- und zahnpflegemittel
EP0523776A3 (en) * 1991-07-17 1993-05-26 Unilever N.V. Oral compositions containing a phosphopeptide
GB9117315D0 (en) * 1991-08-09 1991-09-25 Unilever Plc Method of controlling dental tartar and compositions for use therein
EP0651652B1 (en) * 1992-06-29 2000-02-09 The University Of Melbourne Treatment for sensitive teeth
CA2181109A1 (en) 1995-07-18 1997-01-19 Nobuko Imajo Polypeptide and process for measuring living body components using the same
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
AUPO566297A0 (en) 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6846500B1 (en) * 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
WO2000057842A2 (en) * 1999-03-25 2000-10-05 Warner-Lambert Company Oral care chewing gums and confections
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
EP1811942B1 (en) 2004-11-16 2011-10-05 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
US8710114B2 (en) 2004-11-16 2014-04-29 3M Innovative Properties Company Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
ATE480214T1 (de) * 2004-11-16 2010-09-15 3M Innovative Properties Co Dentalfüllstoffe, verfahren, zusammensetzungen mit einem caseinat
AU2005306867B2 (en) 2004-11-16 2011-09-08 3M Innovative Properties Company Dental fillers and compositions including phosphate salts
EP3192489A1 (en) 2004-11-25 2017-07-19 The University of Melbourne Stabilized calcium phosphate complexes
EP1888014B1 (en) 2005-06-07 2012-11-14 The University of Melbourne Dental mineralization
CN101208070B (zh) * 2005-06-24 2011-08-31 墨尔本大学 离子络合物
EP1952818A4 (en) 2005-10-27 2009-10-21 Sunstar Inc OSTEOCLASTICIZATION PREPARATION, ORAL AGGREGATION AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES WITH LACTOFERRIN-CONTAINING LIPOSOME
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
PL3086751T3 (pl) 2013-12-24 2023-12-27 The University Of Melbourne Stabilizowane kompozycje cyny
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520417B2 (en) * 1977-09-07 1982-01-28 Sandoz Ltd Pentapeptides and derivatives
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4463092A (en) * 1982-09-27 1984-07-31 Eli Lilly And Company Process for production antibiotic A53868
DE3320175A1 (de) * 1983-06-03 1984-12-06 Boehringer Mannheim Gmbh, 6800 Mannheim Aminosaeure- bzw. peptidderivate, verfahren zu deren herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
WO1987007615A1 (en) 1987-12-17
NO178665B (no) 1996-01-29
DE3751652T2 (de) 1996-07-25
CA1315480C (en) 1993-03-30
FI880629L (fi) 1988-02-11
NO880589L (no) 1988-04-06
NO178665C (no) 1996-05-08
AU593365B2 (en) 1990-02-08
DK70388A (da) 1988-04-11
ATE132161T1 (de) 1996-01-15
JPH0776235B2 (ja) 1995-08-16
AU7548387A (en) 1988-01-11
NZ220673A (en) 1990-05-28
JPS63503459A (ja) 1988-12-15
FI880629A0 (fi) 1988-02-11
EP0268663A4 (en) 1990-04-10
NO880589D0 (no) 1988-02-10
DK173565B1 (da) 2001-03-19
FI92709C (fi) 1994-12-27
HUT47309A (en) 1989-02-28
EP0268663B1 (en) 1995-12-27
DE3751652D1 (en) 1996-02-08
EP0268663A1 (en) 1988-06-01
DK70388D0 (da) 1988-02-11
FI92709B (fi) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE132161T1 (de) Phosphopeptide
DE68924795D1 (de) Verfahren zur Radiomarkierung von Proteinen.
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
DE69000988D1 (de) Steuerungssystem fuer den motorzyklus.
DE69101760D1 (de) Mittel zur Verhinderung von Calcium enthaltenden Ablagerungen.
DE3687103D1 (de) Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
DE59300243D1 (de) Verfahren zur Herstellung von 3,5-Difluoranilin.
ATE72963T1 (de) Konditionierfluessigkeiten von zahn- oder knochensubstanz.
ATE60583T1 (de) Verfahren zur herstellung von 2,2,6,6-tetraalkyl- 4-piperidylaminen.
DE59400013D1 (de) Verfahren zur Herstellung von Methylchlorsilanen.
DE3873243D1 (de) Ventilschaftabdichtungsbefestigung.
DE69202115D1 (de) Verfahren zur Darstellung von 1,2-Naphtho-Chinondiazido-5-Sulfonylchlorid.
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DE69103214D1 (de) Verfahren zur Reinigung von Glycin.
ATE356831T1 (de) Neuer galaninrezeptor
DE69313832D1 (de) Verfahren zur Herstellung von 2,4-Dihydroxydiphenylsulfon
AR224003A1 (es) Compuestos herbicidas derivados de(2,6-dihaloisonicotinol)aminoacidos
AR243566A1 (es) Composiciones basadas en poliamida ignifugada.
ATE153344T1 (de) Hemmung von mineralabsetzung mit hilfe von phosphorylierten und ähnlichen polyanionischen peptiden
DE69006820D1 (de) Verfahren zur Herstellung von 1,1-Dichlorotetrafluorethan.
DE69004542D1 (de) Verfahren zur Herstellung von 2,6-Dimethylnaphthalin.
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
DE69108044D1 (de) Verfahren zur verbesserung der fliessencharakteristik von kristallinem ibuprofen.
ATE26109T1 (de) Acetylcystein-salze, ihre herstellung und verwendung.
DE3769749D1 (de) Verfahren zur gewinnung von gereinigten aminosaeuren.